CELLCEUTIX, Inc. (NASDAQOTH:CTIX)

CAPS Rating: 1 out of 5

Results 1 - 6 of 6

Recs

0
Member Avatar eyezie1 (61.72) Submitted: 4/9/2014 2:47:04 AM : Outperform Start Price: $1.57 CTIX Score: +0.68

Brilacidin is a competitor of Cubist and Durata for use in gram positive infections. FDA is fast tracking antibiotics.

Recs

1
Member Avatar zzlangerhans (99.75) Submitted: 4/1/2014 11:56:34 PM : Outperform Start Price: $1.62 CTIX Score: -1.67

Nothing much to see here. The powers that control Cellceutix's share price like to keep it between 1.5 and 2 as the company wanders along their strange path to nowhere. Kevetrin is now a year and a half into a dose escalation phase I trial. At this rate the phase III trials should be completed by 2030. Prurisol has been revealed to be a prodrug of the antiretroviral abacavir, which appently has hitherto unrecognized miraculous antiinflammatory properties. Despite what we have been assured is the inevitable multibillion dollar revenues from these two candidates, Cellceutix purchased the pipeline of defunct biopharma Polymedix and plans to continue development of the abandoned antibiotic Brilacidin. A phase IIb trial of Brilacidin vs daptomycin in skin infections is now enrolling. The share price will most likely wander back to the 2 range as management utilizes their Aspire ATM to pay themselves for their troubles.

Recs

0
Member Avatar adi101 (86.61) Submitted: 3/2/2014 7:45:11 AM : Outperform Start Price: $1.95 CTIX Score: -19.68

clinical stage, 3 drugs in development: new antibiotic, anti psoriasis, cancer drug.

Recs

0
Member Avatar AnsgarJohn (99.02) Submitted: 2/11/2014 10:50:41 AM : Underperform Start Price: $1.84 CTIX Score: +17.06

Swedish boiler room Value of -44 cents :) http://www.gurufocus.com/stock/CTIX

Recs

0
Member Avatar kmac28 (< 20) Submitted: 12/9/2013 6:49:02 AM : Outperform Start Price: $1.62 CTIX Score: -4.77

Fully dependent on current FDA trials at Dana Farber Cancer institute in MA.

Recs

0
Member Avatar jed71 (29.88) Submitted: 9/12/2013 11:38:55 AM : Underperform Start Price: $1.97 CTIX Score: +29.89

Pump N Dump scam.

Results 1 - 6 of 6

Featured Broker Partners


Advertisement